Policy & Regulatory Changes
Expert articles and analysis related to policy & regulatory changes.
AI Summary — Last 30 Days
In the past 30 days, significant regulatory shifts have emerged that directly impact value-based care (VBC) and Medicare/Medicaid policy. On January 26, 2026, CMS issued an Advance Notice of Proposed Rulemaking seeking public input on policies aimed at strengthening the domestic supply chain for personal protective equipment and essential medicines, reflecting lessons learned from the COVID-19 pandemic. This initiative aligns with broader strategic goals of enhancing care delivery systems and optimizing cost efficiencies for Medicare participants, thereby influencing ACOs and population health management strategies amidst an evolving healthcare landscape. Additionally, ongoing discussions surrounding legislative changes impacting ambulatory surgery centers (ASCs) highlight tensions over noncompete agreements and certificate-of-need regulations, which could further shape the competitive dynamics of service delivery within VBC frameworks. For more insights on these developments, see the reports from Behavioral Health Business.
Related Articles
Value-Based Care Emerges as a Strategic Anchor in an Uncertain Regulatory Climate
Value-Based Care Emerges as a Strategic Anchor in an Uncertain Regulatory Climate Behavioral Health Business
Why the FDA regulations on peptide therapy matter
Everyone wants peptides, do you not? That includes Health and Human Services Secretary Robert F. Kennedy Jr. Last week, he announced on the Joe Rogan Experience that the FDA would reverse its restrict...
The states where CON laws could change next
Several states are evaluating changes to their certificate-of-need laws and they look to balance the development and expansion of new healthcare services while avoiding repeated services and managing ...
STAT+: DOJ, Ohio attorney general accuse OhioHealth of driving up prices, crowding out competition
Regulators say Ohio hospital system made it difficult for health insurers to offer cheaper plans.
The Lethal Cost of Regulatory Perfection in Rare Disease
The Lethal Cost of Regulatory Perfection in Rare Disease MedCity News
AI is moving at lightning speed. Can regulation keep up?
Artificial intelligence is swiftly evolving, forcing regulators to figure out how to oversee a technology that can act autonomously and potentially improve itself, experts said at the HIMSS conference...
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections King & Spalding
Noncompetes, CON and more policy changes shaking up ASCs
From new regulations surrounding noncompete clauses to certificate-of-need updates, there have been recent legislative changes at both the state level that will impact the business and operations of A...
STAT+: As controversial decisions mount, FDA shuns public advisory meetings
The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.
North Carolina appeals court rejects AdventHealth CON complaint
The North Carolina Court of Appeals rejected AdventHealth Hendersonville’s (N.C.) challenge of regulators’ decision to award Asheville, N.C.-based Mission Health a certificate-of-need approval to deve...